Bon Secours St. Francis Launches Comprehensive Breast Program

Bon Secours St. Francis launched a new, comprehensive breast program, designed to bring together state-of-the-art technology, multidisciplinary experience, and a patient-centered approach to enhance breast health and cancer care in the Upstate.

As part of this initiative, Bon Secours is pleased to welcome Dr. Jennifer Beatty, a highly skilled and respected breast surgeon, as the program’s medical director. She will work with multidisciplinary teams to streamline processes, ensuring a highly reliable workflow and reducing the time between imaging, diagnostics, and treatment for breast cancer patients.

Dr. Beatty earned her Doctor of Osteopathic Medicine from Kansas City University of Medicine and Bioscience before completing her residency at Ohio University and the University of Pittsburgh Medical Center. Board certified by the American Osteopathic Board of Surgery and a fellow of the American College of Surgeons, Dr. Beatty brings a wealth of specialized training, including certifications in oncoplastic surgery, Hidden Scar™ techniques, and laser treatments.

Recognizing the vital role of nutrition in cancer care, Dr. Beatty pursued further education and became licensed in oncology nutrition to better support her patients. She also serves on the American Cancer Society’s Board of Executive Leadership Council and actively participates in breast cancer research to ensure patients have access to cutting-edge treatments.

“We are in an exciting new era of breast cancer care, where early detection and personalized treatment plans can make all the difference,” said Dr. Beatty. “By combining our advanced technology with a compassionate, patient-first approach, we will continue to improve outcomes and provide comprehensive support for every patient on their journey to healing.”

This new, comprehensive breast program will integrate services already offered at the Pearlie Harris Center for Breast Health and the Bon Secours St. Francis Cancer Center, ensuring seamless coordination of care. Additionally, a new surgical procedure suite is set to open in May at the cancer center, allowing for on-site, minimally invasive procedures to enhance patient convenience and outcomes for multiple surgical specialties. Plans are also underway to open a comprehensive breast clinic on the campus of Bon Secours St. Francis Eastside’s campus later this year, further expanding access to specialized breast care services.

Supporting early detection efforts, Bon Secours will continue utilizing its two mobile mammography units, which have been instrumental in providing accessible breast cancer screenings to communities across the region.

For more information about the new breast program or other oncology services available at Bon Secours St. Francis, visit bonsecours.com.

About Bon Secours

Bon Secours St. Francis is part of Bon Secours Mercy Health (BSMH), one of the 20 largest health systems in the United States and the fifth-largest Catholic health system in the country. The ministry’s quality, compassionate care is provided by more than 60,000 associates serving communities in Florida, Kentucky, Maryland, New York, Ohio, South Carolina, and Virginia, as well as throughout Ireland. Bon Secours Mercy Health provides care for patients more than 11 million times annually through its network of more than 1,200 care sites, which includes 49 hospitals. In 2023, BSMH provided more than $600 million dollars in community investments across five states, ensuring that cost is not a barrier to health care for our patients in need. Locally, Bon Secours St. Francis provides compassionate medical care to thousands of area residents through Bon Secours St. Francis Downtown and Bon Secours St. Francis Eastside, as well as a network of primary and specialty care practices, and ambulatory care sites across the Greenville region. The mission of Bon Secours St. Francis is to extend the compassionate ministry of Jesus by improving the health and well-being of our communities and bring good help to those in need, especially people who are poor, dying and underserved. For more information, visit BonSecours.com.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Paige Durham

SCbio is pleased to welcome Paige Durham to the team as communications coordinator to creatively and effectively communicate the value of the life science association’s programs and initiatives.

Durham will be responsible for developing and distributing high-quality content across multiple communications channels to build, advance and grow South Carolina’s life sciences industry, a key business sector for economic prosperity for the Palmetto State.

“SCbio is excited to welcome Paige to our team as our new communications coordinator. Paige brings fresh ideas and a strong background in communications that will be invaluable as we continue to strengthen our engagement with our audience,” said SCbio President and CEO James Chappell. “We are confident that her skills and experience will be crucial in advancing our communication strategies and supporting our mission.”

Before joining SCbio, Durham was the Membership and Communications Manager at the South Carolina Pharmacy Association (SCPhA), where she used her photography, design and writing skills to create content tailored to pharmacy professionals. Durham’s effective communication skills guaranteed the delivery of brand-specific material that captured the eye of her audience.

During her time at SCPhA, Durham created and edited the Palmetto Pharmacist Journal, using her creative vision to showcase members, educational institutions and industry news. Her communications efforts successfully gained new followers for the organization over the course of a year, increasing brand visibility and promoting the pharmacy profession.

Durham holds a Bachelor of Science in hospitality and tourism management and a Bachelor of Science in business administration from the College of Charleston.

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.